Tonix Pharmaceuticals
TNXP | NASDAQ
$2.88
-$0.13 (-4.32%)
At close: Nov 16, 2026, 4:00 PM ET
$2.88
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:50 PM ET
-4.32%
(1D)No price chart data available for 1D timeframe.
Rating
52
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #241/1021 (Top 24%)
Key Statistics
Market Data
Market Cap $55.96M
1D Range
2.81 3.08
52W Range
2.81 19.89
Valuation (TTM)
PE -0.23
PB 0.28
EV/EBITDA -0.31
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $22.50
Cash Flow
FCF Yield -303.9%
SBC Adj. FCF Yield -318.7%
SBC Impact -4.9%
Margins
Gross Margin 86.9%
Operating Margin -436.3%
FCF Margin -395.0%
Growth (CAGR)
Revenue 3Y | 5Y 121.0% |
67.3%
Dil EPS 3Y | 5Y 149.2% |
12.6%
FCF 3Y | 5Y -47.4% |
2.4%
Returns
ROA -74655.8%
ROE -81.0%
ROIC -93549.8%
Financial Health
Net Cash
$162.79K
Current Ratio 4.57
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and com...
Sector Healthcare
Industry Biotechnology
Employees 142
IPO Date May 10, 2012
Website www.tonixpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 9, 2026
EPS
-$2.89
Miss -20.92%
YoY:
+19.50% REV
$17.23M
Beat +5.62%
YoY:
+423.83%Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove TNXP